RWE | Prime

Prime Global acquires award-winning digital agency earthware, enhancing digital and technology expertise

Prime Global 29 September, 2022

Prime Global, a recognised global leader in medical communications, evidence and access, and patient engagement, has acquired earthware, an award-winning creative digital agency that creates life-changing solutions to real world healthcare problems. earthware joins Prime Global in supporting pharma and biotech clients at every step of the healthcare journey; their industry-leading technology expertise will complement Prime Global’s scientific heritage and proven delivery, enhancing and expanding Prime Global’s existing digital capabilities.

Prime Global acquires HCD Economics, creating an innovative evidence-generating, HEOR, value & communications group

Prime Global 24 January, 2022

Prime Global, a recognised global leader in medical communications and market access, has strengthened its Evidence, Access, and Patient Practice with the acquisition of HCD Economics, an academically aligned organisation focusing on health economics and outcomes research (HEOR) and real-world evidence (RWE). HCD will work closely with Prime Global’s highly experienced medical communications agencies and specialist consultancies, including market access consultancy, Prime Access, and patient engagement experts, Prime Patient, to deliver integrated evidence-led services.

Evidence or Opinion: what is really driving decisions following accelerated approvals?

Prime Global 3 September, 2021

Delivery of confirmatory studies following any accelerated approval has been an area of growth and contention. Sue O’Leary, Senior Vice President of Prime Access, and Jenny Blackham, Vice President of Client Partnerships, take a closer look at what is happening.